This prospective study investigated the prevalence and clinical implications of EGFR mutations in Moroccan NSCLC patients.<h4>Methods</h4>A cohort of 302 NSCLC patients was analyzed for EGFR mutations using multiple techniques. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.